Login / Signup

Esophageal Cancer: Should Gender Be Considered as an Influential Factor for Patient Safety in Drug Treatment?

Fengxia LiuHelin FengSumin GuoYuhan ChenQingyi LiuFeng WuWeikuan GuBao-En Shan
Published in: Journal of oncology (2019)
Gender difference in response to treatment potentially most likely exists in esophageal cancer patients, regardless of age, race, and drugs.
Keyphrases
  • patient safety
  • mental health
  • quality improvement
  • combination therapy
  • adverse drug
  • smoking cessation